The center aims to create new medicines and innovative treatment materials by pursuing the synthesis of sequence-defined chemical polymers.
The research will be conducted by a team of chemists, biologists, engineers and data scientists in 14 laboratories at UC Berkeley, New Haven, Conn.-based Yale University, Stanford (Calif.) University, Ithaca, N.Y.-based Cornell University, Boston College and Chicago-based St. Jude Children’s Research Hospital.
More articles on health IT:
5 Epic program execs share tips on optimization during times of crisis
5 hospital-at-home initiatives from Adventist Health, Mayo Clinic & more
NIH boosts genomics initiatives with $75M funding
